Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News

VR May Help Curb Cravings in Substance Use Disorder

Virtual reality-based interventions are associated with significantly reduced cravings in patients with various substance use disorders, a new meta-analysis shows.

Infections Tied to Asthma Attacks on Benralizumab Therapy

In patients with eosinophilic asthma on benralizumab, attacks often feature airway neutrophilia, respiratory viruses, and microbiome shifts, indicating infections are a key cause of exacerbations.

EMA Holds Valproate Precautions Despite Mixed Evidence

EMA has found inconsistent data on developmental disorders in children of fathers using valproate before conception and retains existing precautions.

Housing Instability Can Threaten Diabetic Retinopathy Care

Analysis of electronic health record data shows unhoused patients with diabetes have more severe diabetic retinopathy and higher rates of vision-threatening complications than stably housed patients.

Congo's Ebola Outbreak Spreads to New Health Zones

Congo's Ebola outbreak has spread ⁠to three new health zones, according to ⁠a government report published on Thursday that ⁠showed the ‌number of confirmed cases had risen...

India Raises Price Cap on Cancer Drugs to Tackle Shortage

India's drug price regulator raised ceiling rates for two key platinum-based cancer drugs by 50% after a surge ⁠in raw material costs triggered widespread shortages,...

Todays Updates

Inside the Major Findings From the NHS-Galleri Trial

The largest randomized study of a multicancer blood test found no reduction in late-stage cancers, while raising new questions about stage shift, mortality benefit, and population screening.

Talquetamab Combos Show Survival Benefit in r/r Myeloma

Interim findings from the phase 3 MonumenTAL-3 trial highlight overall and progression-free survival as well as response rates compared with standard therapy.

Todays Updates

Inside the Major Findings From the NHS-Galleri Trial

The largest randomized study of a multicancer blood test found no reduction in late-stage cancers, while raising new questions about stage shift, mortality benefit, and population screening.

Talquetamab Combos Show Survival Benefit in r/r Myeloma

Interim findings from the phase 3 MonumenTAL-3 trial highlight overall and progression-free survival as well as response rates compared with standard therapy.

Latest News

Virtual reality-based interventions are associated with significantly reduced cravings in patients with various substance use disorders, a new meta-analysis shows.

In patients with eosinophilic asthma on benralizumab, attacks often feature airway neutrophilia, respiratory viruses, and microbiome shifts, indicating infections are a key cause of exacerbations.

EMA has found inconsistent data on developmental disorders in children of fathers using valproate before conception and retains existing precautions.

Analysis of electronic health record data shows unhoused patients with diabetes have more severe diabetic retinopathy and higher rates of vision-threatening complications than stably housed patients.

Congo's Ebola outbreak has spread ⁠to three new health zones, according to ⁠a government report published on Thursday that ⁠showed the ‌number of confirmed cases had risen...

India's drug price regulator raised ceiling rates for two key platinum-based cancer drugs by 50% after a surge ⁠in raw material costs triggered widespread shortages,...

News All Time

Medical Empathy: Laura Dern and Diane Ladd’s IPF Journey

The Oscar-winning actress shares what she learned as a caregiver, and what doctors can do to give patients with IPF more hope and resources.

Low Outdoor Exposure in Winter Linked to Paediatric MS Risk

Reduced outdoor exposure during winter in early childhood is linked to higher odds of developing paediatric multiple sclerosis across early-life age groups.

COPD Surfaces During Lung Cancer Screening

Leveraging lung cancer screening can improve chronic obstructive pulmonary disease detection and intervention in underserved populations.

Psilocybin May Boost Abstinence in Cocaine Use Disorder

Psilocybin added to psychotherapy is associated with a greater likelihood of abstinence in cocaine use disorder than an adjunct active placebo, a study shows.

Ebola Recoveries Bring Signs Of Hope in DRC as Suspected Cases Emerge Outside Africa

Four nurses who were being treated for Ebola caused by the Bundibugyo strain of the virus have been discharged from a hospital in Bunia in the Democratic ⁠Republic of Congo...

Dual Pulmonary Hypertension Therapy Safer for Angioplasty

Dual therapy for pulmonary hypertension before balloon pulmonary angioplasty is linked to fewer thoracic complications than monotherapy in patients with chronic thromboembolic pulmonary hypertension.

Eye Inflammation Tied to Anti-Adalimumab Antibody Formation

Patients with autoimmune diseases who experience ocular inflammation while on adalimumab have an increased risk of developing antibodies against the drug, according to a recent retrospective study.

Ralinepag Offers Once Daily Oral Option for PAH

Phase 3 data provide the foundation for a planned New Drug Application.

WHO Chief Says Fast-moving Ebola Epidemic Is Outpacing Response Efforts

The head of the World Health Organization said on Monday that the ⁠fast-moving Ebola outbreak in Democratic Republic of Congo and Uganda was outpacing response ⁠efforts,...

Suspected and Confirmed Measles Deaths Top 500 in Bangladesh

It's one of the country's worst outbreaks in decades.

Experimental Treatments Could Help US Ebola Patient

The U.S. missionary who tested positive for Ebola and is undergoing treatment in a German hospital has been given drugs aimed at reducing disease symptoms after exposure to...

Pill for Obstructive Sleep Apnea Shows Potential

AD109 works by targeting neuromuscular dysfunction of upper airway muscles during sleep, representing a potential new strategy to help people with obstructive sleep apnea.

Accuracy of Proposed CTE Diagnostic Criteria Questioned

Most individuals who meet proposed clinical criteria for chronic traumatic encephalopathy lack the disease’s hallmark pathology at autopsy, raising questions about the criteria’s diagnostic reliability.

EMA OKs New Option for Pulmonary Fibrosis

The oral therapy is intended for adults with idiopathic pulmonary fibrosis or progressive pulmonary fibrosis, two fibrotic lung diseases with limited treatment options.

Higher Caffeine Intake Tied to Greater Depression Severity

Insomnia, sleepiness, fatigue, and stress were associated with higher depression scores, but caffeine appeared to lessen the association between depression and severe insomnia.

First Real-World Study Supports Sotatercept for PAH

Researchers share their experience with sotatercept in 91 patients with pulmonary arterial hypertension, the first report on outcomes outside clinical studies.

Recommended News For You

Living near St. Louis-area Coldwater Creek during childhood linked with higher risk of cancer from radiation

Fitness levels for the heart and lungs are linked to a lower mortality from cancer in men.

Oleanolic acid from grapes may increase chemotherapy effectiveness

Research finds low uptake of supportive care at the end-of-life for patients with advanced cancer

New BiTE Agent for Small Cell Lung Cancer Approved by the FDA.

Pressing the Sleep button could have a positive impact on cognition.

Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials

Recommended Articles For You

Revolutionizing Lung Cancer Treatment: Exploring the Benefits of Wedge Resection Surgery 

Neoadjuvant Radiotherapy & Endocrine Therapy in ER+ Breast Cancer Treatment 

The Future of Cancer Care: Genetics, Support Systems, and Emerging Therapies 

Unleashing the Power of AI: A Systematic Review of Predictive Biomarker Discovery in Immuno-Oncology 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

HER2 ADC Shows Promise in Recurrent Endometrial Cancer

2.

Pressing the Sleep button could have a positive impact on cognition.

3.

These Medical Doctors Are Real Comedians: Should Doctors Be Funnier?

4.

Muscle Strength, Fitness Linked to Lower Mortality Risk in Patients With Cancer

5.

Chemoradiation Plus Immunotherapy Fails to Improve Survival in Limited-Stage SCLC

1.

How Cancer Cells Evade Immune Destruction and the Fight Back

2.

Exploring Innovative Approaches to Esophageal Cancer Treatment

3.

Hepatocellular Carcinoma: Emerging Trends and Innovations in Diagnosis and Management

4.

Contemporary Methods in Hematology Across Clinical Settings

5.

Uncovering New Hope for Follicular Lymphoma Patients

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2

2.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV

3.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V

4.

Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World

5.

Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot